KR101602802B1 - 고열 홍조에 대한 스테로이드 치료 - Google Patents

고열 홍조에 대한 스테로이드 치료 Download PDF

Info

Publication number
KR101602802B1
KR101602802B1 KR1020107025191A KR20107025191A KR101602802B1 KR 101602802 B1 KR101602802 B1 KR 101602802B1 KR 1020107025191 A KR1020107025191 A KR 1020107025191A KR 20107025191 A KR20107025191 A KR 20107025191A KR 101602802 B1 KR101602802 B1 KR 101602802B1
Authority
KR
South Korea
Prior art keywords
delete delete
epoxy
hydroxyestre
male
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020107025191A
Other languages
English (en)
Korean (ko)
Other versions
KR20110014147A (ko
Inventor
루이스 몬티
Original Assignee
페린 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 페린 파마슈티칼즈, 인코포레이티드 filed Critical 페린 파마슈티칼즈, 인코포레이티드
Publication of KR20110014147A publication Critical patent/KR20110014147A/ko
Application granted granted Critical
Publication of KR101602802B1 publication Critical patent/KR101602802B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
KR1020107025191A 2008-04-09 2009-04-09 고열 홍조에 대한 스테로이드 치료 Active KR101602802B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
US61/123,622 2008-04-09

Publications (2)

Publication Number Publication Date
KR20110014147A KR20110014147A (ko) 2011-02-10
KR101602802B1 true KR101602802B1 (ko) 2016-03-11

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107025191A Active KR101602802B1 (ko) 2008-04-09 2009-04-09 고열 홍조에 대한 스테로이드 치료

Country Status (10)

Country Link
US (2) US20090258040A1 (cg-RX-API-DMAC10.html)
EP (1) EP2278880B1 (cg-RX-API-DMAC10.html)
JP (1) JP5524177B2 (cg-RX-API-DMAC10.html)
KR (1) KR101602802B1 (cg-RX-API-DMAC10.html)
CN (1) CN102056484B (cg-RX-API-DMAC10.html)
AU (1) AU2009234159B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0910637A2 (cg-RX-API-DMAC10.html)
DK (1) DK2278880T3 (cg-RX-API-DMAC10.html)
MX (1) MX2010011063A (cg-RX-API-DMAC10.html)
WO (1) WO2009126825A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018297270B2 (en) * 2017-07-06 2024-02-15 Dignity Health Novel treatment for hot flushes
DK3955933T3 (da) 2019-04-15 2024-02-12 Vistagen Therapeutics Inc Behandling af migræne
MX2025014339A (es) * 2023-06-04 2026-02-03 Vistagen Therapeutics Inc Metodo para mejorar el rendimiento cognitivo o psicomotor
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057439A (en) 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US20010041699A1 (en) 1999-04-02 2001-11-15 Robert G. Bell Method for treating osteoporosis in castrated prostatic cancer patients
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
JP4450435B2 (ja) * 1996-07-23 2010-04-14 フィーリン・ファーマシューティカルズ・インコーポレイテッド Pmsおよび不安の症状を緩和する、vnoにおける神経化学刺激物質としてのステロイド
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
SI3045182T1 (en) * 2005-11-14 2018-08-31 Teva Pharmaceuticals International Gmbh An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057439A (en) 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US20010041699A1 (en) 1999-04-02 2001-11-15 Robert G. Bell Method for treating osteoporosis in castrated prostatic cancer patients
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Oestrogen protection against Acute digitalis otxiciy in dogs, Nature, 4781, 1117-1118(1961.06.17.)

Also Published As

Publication number Publication date
BRPI0910637A2 (pt) 2015-07-28
AU2009234159B2 (en) 2013-12-19
KR20110014147A (ko) 2011-02-10
CN102056484A (zh) 2011-05-11
US20090258040A1 (en) 2009-10-15
DK2278880T3 (da) 2012-11-12
US20120108558A1 (en) 2012-05-03
EP2278880B1 (en) 2012-10-10
HK1157142A1 (en) 2012-06-29
MX2010011063A (es) 2010-11-22
US8431559B2 (en) 2013-04-30
WO2009126825A1 (en) 2009-10-15
JP2011518136A (ja) 2011-06-23
CN102056484B (zh) 2014-10-29
EP2278880A1 (en) 2011-02-02
AU2009234159A1 (en) 2009-10-15
EP2278880A4 (en) 2011-08-10
JP5524177B2 (ja) 2014-06-18

Similar Documents

Publication Publication Date Title
JP6012048B2 (ja) アロマターゼ阻害剤およびゲスターゲンを放出する、子宮内膜症を処置するための非経口用剤形
TWI336255B (en) Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiqinone and a bronchodilating agent
CN101583363B (zh) 治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒
US20060106004A1 (en) Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause
US20060254597A1 (en) Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
JPH01502265A (ja) 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出
PT1446128E (pt) Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição
KR20090094437A (ko) 상승-약량 연장 주기 요법을 이용한 호르몬 치료 방법
Manni et al. Antiestrogen-Induced Remissions in Stage IV Breast Cancer¹
Stomati et al. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women
Lauritzen Clinical use of oestrogens and progestogens
JP2004155779A (ja) 更年期症の予防・治療用経口組成物
AU2009234159B2 (en) Steroid treatment for hot flashes
CN101700247A (zh) 利用脱氢表雄酮甾体及抗毒蕈碱药物治疗呼吸道疾病及肺病的组合物、制剂和试剂盒
Esposito Estriol: a weak estrogen or a different hormone?
ES2320662T3 (es) Hormonoterapia restitutiva y tratamiento para la depresion con dienogest.
JP7476229B2 (ja) 片頭痛の治療
HK1157142B (en) Steroid treatment for hot flashes
Studd et al. Symptoms and metabolic sequelae of the menopause
US20250312356A1 (en) Treatment of dysmenorrhea
Wong et al. Exogenous Hormone-Induced Endometrial Changes
LeBlanc Reproduction deduction-Part 2.
DE WATTEVILLE Androgen therapy in gynecology
Keisler The use of oxytocin and progestins to induce and synchronize estrus in beef cattle
HK40068177A (en) Treatment of migraine

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20190226

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20200226

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 10